CLPT peer analysis
ClearPoint Neuro (CLPT) against its competitors: price, today's move, 1-year return and market value side by side.
CLPT and its peers
| Company | Price | Today | 1-year return | Market cap |
|---|---|---|---|---|
| AKBA Akebia Therapeutics | $0.43 | -38.81% | -79.66% | $192.51M |
| CMPS COMPASS Pathways | $7.90 | -8.14% | 19.16% | – |
| CTKB Cytek Biosciences | $5.39 | -8.33% | 37.85% | – |
| LAB Standard BioTools | $0.62 | 0.85% | -48.24% | – |
| OFIX Orthofix | $8.91 | -8.28% | -40.05% | $395.92M |
| SIBN SI-BONE | $24.29 | -2.65% | 58.24% | $1.13B |
| SNDL SNDL | $1.38 | -2.48% | -26.08% | $345.14M |
| VREX Varex Imaging | $18.45 | -0.32% | 56.36% | $786.00M |
| CLPT ClearPoint Neuro | $8.82 | -13.19% | -49.66% | $325.67M |
- CLPT's peers: AKBA (Akebia Therapeutics), CMPS (COMPASS Pathways), CTKB (Cytek Biosciences), LAB (Standard BioTools), OFIX (Orthofix), SIBN (SI-BONE), SNDL (SNDL), VREX (Varex Imaging).
Updated 2026-11-06 11:42 UTC